Indacaterol for chronic obstructive pulmonary disease (COPD).

Indacaterol for chronic obstructive pulmonary disease (COPD).

Item
http://www.wikidata.org/entity/Q37751922
β(2) -adrenoceptor agonists: current and future directionUse of ICS/LABA (extra-fine and non-extra-fine) in elderly asthmaticsComparative efficacy of indacaterol in chronic obstructive pulmonary disease.Emerging drugs for chronic obstructive pulmonary disease.Use of indacaterol for the treatment of COPD: a pharmacokinetic evaluation.Pharmacologic rationale, efficacy and safety of the fixed-dose co-formulation of indacaterol and glycopyrronium.The effects of asthma medications on reactive oxygen species production in human monocytes.The role of indacaterol for chronic obstructive pulmonary disease (COPD).Next generation beta adrenoreceptor agonists for the treatment of asthma.Emerging inhaled long-acting beta-2 adrenoceptor agonists for the treatment of COPD.Indacaterol for the treatment of chronic obstructive pulmonary disease.
P2860

Indacaterol for chronic obstructive pulmonary disease (COPD).

Item
http://www.wikidata.org/entity/Q37751922
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Indacaterol for chronic obstructive pulmonary disease (COPD).
@en
Indacaterol for chronic obstructive pulmonary disease
@nl
type
label
Indacaterol for chronic obstructive pulmonary disease (COPD).
@en
Indacaterol for chronic obstructive pulmonary disease
@nl
prefLabel
Indacaterol for chronic obstructive pulmonary disease (COPD).
@en
Indacaterol for chronic obstructive pulmonary disease
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P5875
P698
P921
P356
P1433
P1476
Indacaterol for chronic obstructive pulmonary disease (COPD).
@en
P2093
P304
P31
P356
10.1358/DOT.2010.46.3.1450070
P433
P478
P577
P5875
P698
P921